SCHEMBL23317227

SCHEMBL23317227

CNc1nc(F)c(CN2CCC3(Cc4ccncc4O3)C2)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317228 0.89 OGA (0.40) —
SCHEMBL23304805 0.81 OGA (0.40) —
SCHEMBL23317511 0.81 CHRNB2 (0.34) —
SCHEMBL23317324 0.76 AVPR1A (0.34) —
SCHEMBL23317310 0.76 AVPR1A (0.33) —
SCHEMBL23317207 0.75 AVPR1A (0.31) —
SCHEMBL29914303 0.72 CCR1 (0.49) —
SCHEMBL29914321 0.71 OGA (0.42) —
SCHEMBL29914288 0.71 OGA (0.41) —
SCHEMBL23317197 0.71 SIGMAR1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086966-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. (US) 2021-05-06 — — WO disclosed
Send feedback